NEW YORK–(BUSINESS WIRE)–CM Life Sciences, Inc. (Nasdaq: CMLFU) (the “Company”) today announced that holders of the Company’s units sold in its initial public offering may elect to separately trade the shares of Class A common stock and redeemable warrants included in its units commencing on or about October 26, 2020. The shares of Class A … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for VITRAKVI® (larotrectinib), which is currently FDA-approved for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) … [Read more…]
Detection of genomic alterations that drive the growth and spread of the tumor can guide treatment decisions for cancer therapies, including available biomarker driven treatments FoundationOne®CDx analyzes substitutions, insertion and deletion alterations (indels), and copy number alterations (CNAs) in 324 genes as well as select rearrangements and genomic signatures across all solid tumors, including the … [Read more…]
TORONTO–(BUSINESS WIRE)–LSO remains concerned by today’s release of the final PMPRB guidelines implementing the federal government’s patented medicine price controls. The final guidelines create a highly risky and uncertain pathway for commercializing new medicines and vaccines in Canada. LSO President and CEO Jason Field wants to ask the Government of Canada “why did it take … [Read more…]
FRANKLIN, Tenn.–(BUSINESS WIRE)–$CYH–Community Health Systems, Inc. (NYSE: CYH) announced today that a subsidiary of the Company has completed the sale of 171-bed San Angelo Community Medical Center in San Angelo, Texas, and its associated assets to subsidiaries of Shannon Health System. The effective date of the transaction is October 24, 2020. The hospital in this … [Read more…]
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational neuromodulator product, DaxibotulinumtoxinA for Injection, today announced new hire grants totaling an aggregate of 58,800 inducement restricted stock awards (“RSAs”) to eleven employees. The RSAs vest over four years, with 25% of the underlying shares … [Read more…]
EXETER, N.H.–(BUSINESS WIRE)–Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary high velocity therapy, which is used to treat patients of all ages suffering from respiratory distress, today announced the appointment of Donald Spence to the Company’s Board of Directors. Mr. Spence … [Read more…]
CALGARY, Alberta–(BUSINESS WIRE)–CUPE 4070 is praising the announcement of rapid COVID testing at the Calgary airport. The union says the announcement is an important step to guide the industry through the pandemic without crashing. Chris Rauenbusch is President of CUPE 4070. He represents over 4,000 cabin crew members at the WestJet group of companies. “The … [Read more…]
A Philip Morris International subsidiary is a shareholder in a biopharmaceutical company that reached agreements with two departments of the Canadian government to accelerate its COVID-19 vaccine candidate efforts LAUSANNE, Switzerland–(BUSINESS WIRE)–Since 2008, Philip Morris Investments B.V. (PMIBV), a subsidiary of Philip Morris International (PMI) (NYSE: PM), has been a shareholder of Medicago (in which … [Read more…]
SIOUX FALLS, S.D.–(BUSINESS WIRE)–Great Western Bank is proud to announce the winners of a one-time award program called Great Gifts of Gratitude. The program recognized the selfless work and unwavering dedication of community members who have gone above and beyond during the pandemic by gifting a total of $70,000 to the 140 winners across our … [Read more…]
